share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/01 16:11

Moomoo AI 已提取核心信息

On September 30, 2024, Aclarion, Inc., a Delaware-incorporated company listed on the Nasdaq Stock Market under the symbol ACON, announced the completion of a financing agreement with accredited investors. The company successfully raised $1 million through the issuance of 1,000 shares of Series C convertible preferred stock at $1,000 per share, along with warrants exercisable for 5,685,049 shares of common stock. The preferred stock comes with a 10% annual dividend, payable quarterly, and is convertible into common stock at $0.1759 per share. The warrants have a 5.5-year term and an exercise price equal to the conversion price of the preferred stock. Aclarion intends to use the proceeds for general corporate purposes. The agreement includes anti-dilution provisions and sets forth conditions under which the company can redeem the preferred shares. Additionally, Aclarion has agreed to file a registration statement with the SEC for the resale of the common stock issuable upon conversion of the preferred stock or exercise of the warrants. The securities were sold in reliance on an exemption from registration under the Securities Act.
On September 30, 2024, Aclarion, Inc., a Delaware-incorporated company listed on the Nasdaq Stock Market under the symbol ACON, announced the completion of a financing agreement with accredited investors. The company successfully raised $1 million through the issuance of 1,000 shares of Series C convertible preferred stock at $1,000 per share, along with warrants exercisable for 5,685,049 shares of common stock. The preferred stock comes with a 10% annual dividend, payable quarterly, and is convertible into common stock at $0.1759 per share. The warrants have a 5.5-year term and an exercise price equal to the conversion price of the preferred stock. Aclarion intends to use the proceeds for general corporate purposes. The agreement includes anti-dilution provisions and sets forth conditions under which the company can redeem the preferred shares. Additionally, Aclarion has agreed to file a registration statement with the SEC for the resale of the common stock issuable upon conversion of the preferred stock or exercise of the warrants. The securities were sold in reliance on an exemption from registration under the Securities Act.
2024年9月30日,Aclarion公司是一家注册在特拉华州的公司,股票在纳斯达克证券交易所上市,股票代码为ACON,宣布与合格投资者完成了融资协议。该公司通过发行每股1000美元的1,000股C系列可转换优先股筹集了一百万美元,同时附带可行使的权证,可换购5,685,049股普通股。优先股每年支付10%的年度股息,每季度支付一次,并且可按0.1759美元每股的价格转换为普通股。权证期限为5.5年,行权价等于优先股的换股价。Aclarion打算将募集资金用于一般企业用途。协议包括防稀释条款,并规定公司可以赎回优先股的条件。此外,Aclarion已同意向SEC提交注册声明,用于再次出售按照优先股转换或权证行权而可发行的普通股。这些证券是依据《证券法》注册豁免销售的。
2024年9月30日,Aclarion公司是一家注册在特拉华州的公司,股票在纳斯达克证券交易所上市,股票代码为ACON,宣布与合格投资者完成了融资协议。该公司通过发行每股1000美元的1,000股C系列可转换优先股筹集了一百万美元,同时附带可行使的权证,可换购5,685,049股普通股。优先股每年支付10%的年度股息,每季度支付一次,并且可按0.1759美元每股的价格转换为普通股。权证期限为5.5年,行权价等于优先股的换股价。Aclarion打算将募集资金用于一般企业用途。协议包括防稀释条款,并规定公司可以赎回优先股的条件。此外,Aclarion已同意向SEC提交注册声明,用于再次出售按照优先股转换或权证行权而可发行的普通股。这些证券是依据《证券法》注册豁免销售的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息